A detailed report study on flow Cytometry market by AMR observed that the value of flow symmetry is expected to reach $6.5 billion by 2020 from $3 billion in 2012 at a CAGR of 30.9%. Many clinical institutions are going for innovative and path breaking technologies to increase precisions and produce firm results.
As per the observation made by AMR analysts, Cytometry is moving towards growth and with advanced procedures of Cytometry like multi-parameter and multi-color has only made its foothold strong in the market. They further projected that developed economies and Asia Pacific region will witness a very high growth because of rising improved health care demand with economy of scale. Analysts credit the growth of Flow Cytometry to factors like ageing population, increased chronic diseases, need for an improved healthcare system and enhance and effective diagnosis of medical conditions.
High cost of instrumentation involved in flow Cytometry will deter its growth, as per AMR’s report. AMR analysts have chalked out certain factors that will hamper the growth of Flow Cytometry market; they are large size of instrumentation and high cost, requirement of skilled individuals for its operation and less awareness among prospect users.
Flow Cytometry market is divided into product, technology, end-users and application market. Under product segment, Instrument market is leading in terms of revenue and will continue to be dominant till 2020. With a CAGR of 12% by the end of 2020, reagent market is predicted to witness the highest growth.
In terms of regional analysis, North America was leading with revenue share of 43.5% i.e. $1.2 billion in 2011. It is estimated by AMR analysts to further reach a mark of $2.8 billion by 2020 at a CAGR of 10.1%.